|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities available for sale, at fair value, as of June 30, 2026 and December 31, 2025, at an amortized cost of $57,287 and $57,161, respectively, net of allowance for credit losses of $78 and $112, respectively, and includes pledged fixed maturity securities of $470 and $446, respectively, related to secured trust deposits | ||||||||||||||||||||
| Fixed maturity securities, at fair value under the fair value option | ||||||||||||||||||||
| Securities, at fair value | ||||||||||||||||||||
| Preferred equity securities | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Derivative investments | ||||||||||||||||||||
| Mortgage loans, net of allowance of $108 and $86 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Investments in unconsolidated affiliates (2026 and 2025 includes $277 and $262 related to investments held by consolidated variable interest entities ("VIEs") and 2026 and 2025 include certain investments at fair value of $267 and $270, respectively) | ||||||||||||||||||||
| Other long-term investments (2026 and 2025 include $264 and $248 related to investments held by consolidated VIEs) | ||||||||||||||||||||
| Short-term investments (2026 and 2025 include $34 and $116 related to investments held by consolidated VIEs) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents, as of June 30, 2026 and December 31, 2025 includes $546 and $261, respectively, of pledged cash related to secured trust deposits | ||||||||||||||||||||
| Trade and notes receivables, net of allowance of $25 and $31 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Reinsurance recoverable, net of allowance of $19 and $18 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Market risk benefits asset | ||||||||||||||||||||
| Lease assets | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Title plants | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Contractholder funds | ||||||||||||||||||||
| Future policy benefits | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Market risk benefits liability | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Reserve for title claim losses | ||||||||||||||||||||
| Funds withheld for reinsurance liabilities | ||||||||||||||||||||
| Secured trust deposits | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| FNF common stock, $0.0001 par value; authorized 600 shares as of June 30, 2026 and December 31, 2025; outstanding of 268 and 271 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; authorized 50 shares; issued and outstanding, none | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss ("AOCL") | ||||||||||||||||||||
| Treasury stock, 64 and 61 shares as of June 30, 2026 and December 31, 2025, respectively, at cost | ||||||||||||||||||||
| Total Fidelity National Financial, Inc. shareholders’ equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common stock, shares, outstanding (in shares) | ||||||||||||||||||||
Loading...